Published in Antimicrob Agents Chemother on September 05, 2006
Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev (2009) 3.41
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malar J (2006) 2.19
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J (2008) 1.86
Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Antimicrob Agents Chemother (2007) 1.75
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J (2007) 1.56
The rationale and plan for creating a World Antimalarial Resistance Network (WARN). Malar J (2007) 1.25
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières. PLoS Med (2008) 0.98
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria. PLoS Med (2008) 0.94
Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh. Malar J (2012) 0.90
The effect of varying analytical methods on estimates of anti-malarial clinical efficacy. Malar J (2009) 0.84
Uncertain outcomes: adjusting for misclassification in antimalarial efficacy studies. Epidemiol Infect (2010) 0.75
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
Malaria. Lancet (2005) 7.37
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. World Health Organ Tech Rep Ser (1973) 1.88
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg (2004) 1.88
Genotyping of Plasmodium spp. Nested PCR. Methods Mol Med (2002) 1.66
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health (2005) 1.48
Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. Trop Med Int Health (1998) 1.43
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg (2005) 1.40
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop Med Int Health (2004) 1.00
Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. Trans R Soc Trop Med Hyg (2003) 0.95
Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. Am J Trop Med Hyg (2001) 0.91
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. Trans R Soc Trop Med Hyg (2005) 0.87
4 million neonatal deaths: when? Where? Why? Lancet (2005) 28.92
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet (2012) 25.96
Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet (2005) 18.87
What works? Interventions for maternal and child undernutrition and survival. Lancet (2008) 13.89
Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet (2002) 11.72
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet (2012) 10.21
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis (2005) 5.58
Stillbirths: Where? When? Why? How to make the data count? Lancet (2011) 5.40
Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLoS Med (2011) 5.33
Causes of deaths in children younger than 5 years in China in 2008. Lancet (2010) 5.02
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial. Lancet (2011) 4.42
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev (2011) 4.11
The influence of distance and level of care on delivery place in rural Zambia: a study of linked national data in a geographic information system. PLoS Med (2011) 4.04
Implementing community-based perinatal care: results from a pilot study in rural Pakistan. Bull World Health Organ (2008) 3.99
Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol (2010) 3.90
Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet (2010) 3.82
Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health (2003) 3.58
'Kangaroo mother care' to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol (2010) 3.55
60 Million non-facility births: who can deliver in community settings to reduce intrapartum-related deaths? Int J Gynaecol Obstet (2009) 3.48
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet (2013) 3.45
Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J (2008) 3.42
30 years after Alma-Ata: has primary health care worked in countries? Lancet (2008) 3.40
Born too soon: the global epidemiology of 15 million preterm births. Reprod Health (2013) 3.32
Alma-Ata: Rebirth and Revision 6 Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Lancet (2008) 3.32
Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev (2009) 3.26
3.6 million neonatal deaths--what is progressing and what is not? Semin Perinatol (2010) 3.26
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J (2008) 3.24
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg (2004) 3.18
Violence and mortality in West Darfur, Sudan (2003-04): epidemiological evidence from four surveys. Lancet (2004) 3.14
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet (2012) 2.98
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet (2011) 2.81
Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan (2012) 2.80
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
High ANC coverage and low skilled attendance in a rural Tanzanian district: a case for implementing a birth plan intervention. BMC Pregnancy Childbirth (2010) 2.76
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J (2009) 2.64
Fumagillin treatment of intestinal microsporidiosis. N Engl J Med (2002) 2.52
Why are 4 million newborn babies dying each year? Lancet (2004) 2.50
Saving newborn lives in Asia and Africa: cost and impact of phased scale-up of interventions within the continuum of care. Health Policy Plan (2008) 2.48
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med (2014) 2.24
Forecasting malaria incidence based on monthly case reports and environmental factors in Karuzi, Burundi, 1997-2003. Malar J (2007) 2.17
Linking families and facilities for care at birth: what works to avert intrapartum-related deaths? Int J Gynaecol Obstet (2009) 2.12
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA (2010) 2.12
Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol (2010) 2.12
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors (2012) 2.08
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol (2002) 2.04
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 2.04
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2010) 2.04
Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda. J Trop Pediatr (2009) 2.02
Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis (2006) 2.01
Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health (2011) 1.95
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg (2006) 1.92
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS (2007) 1.88
Malaria in adolescence: burden of disease, consequences, and opportunities for intervention. Lancet Infect Dis (2006) 1.86
Pre-emptive war epidemiology: lessons from the Democratic Republic of Congo. Lancet (2006) 1.83
Comparing modelled predictions of neonatal mortality impacts using LiST with observed results of community-based intervention trials in South Asia. Int J Epidemiol (2010) 1.83
Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. J Clin Microbiol (2005) 1.82
Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol (2010) 1.81
A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis (2006) 1.80
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
Four million neonatal deaths: counting and attribution of cause of death. Paediatr Perinat Epidemiol (2008) 1.80
Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health (2011) 1.77
Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS (2007) 1.77
Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J (2008) 1.76
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 1.76
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol (2010) 1.73
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series. PLoS Negl Trop Dis (2007) 1.72
Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials (2006) 1.72
Open science is a research accelerator. Nat Chem (2011) 1.70
Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth (2014) 1.70
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg (2003) 1.69
Why are 4 million newborn babies dying every year? Lancet (2004) 1.69
Effect of geographical access to health facilities on child mortality in rural Ethiopia: a community based cross sectional study. PLoS One (2012) 1.68
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Malar J (2011) 1.66
Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial. Am J Trop Med Hyg (2012) 1.66
Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health (2011) 1.64
Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health (2011) 1.64
Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). Malar J (2007) 1.63